Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, China, Israel, and internationally. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it develops, markets, and distributes software for internet users; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops, produces, and markets miniaturized imaging equipment, visualization solutions, and resistant cameras; electric vehicles; and wireless vehicle battery charging technologies. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.

Medigus Ltd.

Xylo Technologies is a technology-based company engaged in advancing innovative solutions for large-scale market applications, particularly in the fields of advanced medical solutions, online e-commerce, and electric vehicles. Self-described as focusing on innovative growth partnerships.

Metric
Company Name	Medigus Ltd.
Symbol	MDGS
MSH ID	COM:MEDIGUS
Market	STOCKS
Sector	Healthcare
Industry	Medical - Devices
Country	IL
Stage
Employee Count	77
Website	medigus.com
LinkedIn
Founders

Metric
Market Cap	4.47M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	91.72M
Revenue (LTM)
Revenue (NTM)
Gross Profit	11.84M
EBITDA	-12.84M
Operating Income	-23.32M
Net Income	-16.02M
EPS	-9.50
Diluted EPS	-9.50
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.15
Operating Profit Margin	-0.09
EBITDA Margin	-0.14
Net Profit Margin	-0.13
Return on Equity	-0.53
Return on Assets	-0.22
Return on Capital Employed	-0.24

COM:MEDIGUS

Xylo Technologies

Last Close

2.14

17/04 20:00

Market Cap

4.47M

Beta: -

Volume Today

25.63K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-0.51
P/B Ratio	0.13
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	0.03
EV Multiple	-0.53

Metric
Days Sales Outstanding	100.26
Days Payables Outstanding	96.29
Days Inventory Outstanding	7.89
Operating Cycle	84.91
Cash Conversion Cycle	27.24
Asset Turnover	2.17

Metric
Operating Cash Flow	-6.25M
Free Cash Flow	-7.99M
Cash Flow to Debt	-0.66
Operating Cash Flow/Sales	-0.06
Free Cash Flow Yield	-1.05

Metric
Cash & Equivalents	9.36M
Accounts Receivable	9.13M
Inventory	2.39M
Goodwill	8.55M
Debt to Capitalization	0.29
Debt to Assets	0.10
Current Ratio	1.39
Quick Ratio	1.22

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.01
R&D to Revenue	0.05
SG&A to Revenue	0.15